Pevonedistat
Pevonedistat-2003
Phase 2 small_molecule terminated
Quick answer
Pevonedistat for Myelodysplastic Syndromes (MDS) is a Phase 2 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Myelodysplastic Syndromes (MDS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated